FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4213306515> ?p ?o ?g. }

• W4213306515 abstract "Osimertinib, a 3rd generation epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI), is the first-line standard-of-care for EGFR-mutant non-small cell lung cancer (NSCLC) patients, while acquired drug resistance will inevitably occur. Interleukin-6 (IL-6) is a keystone cytokine in inflammation and cancer, while its role in osimertinib efficacy was unknown. Here we show that clinically, plasma IL-6 level predicts osimertinib efficacy in EGFR mutant NSCLC patients. Highly increased IL-6 levels are found in patients with acquired resistance to osimertinib. Addition of IL-6 or exogenous overexpression of IL-6 directly induces osimertinib resistance. Proteomics reveals LAMA5 (Laminin α5) and PTK2, protein tyrosine kinase 2, also called focal adhesion kinase (FAK), are activated in osimertinib-resistant cells, and siRNA knockdown of LAMA5 or PTK2 reverses IL-6-mediated osimertinib resistance. Next, using a large-scale compound screening, we identify ibrutinib as a potent inhibitor of IL-6 and Laminin α5/FAK signaling, which shows synergy with osimertinib in osimertinib-resistant cells with high IL-6 levels, but not in those with low IL-6 levels. In vivo, this combination inhibits tumor growth of xenografts bearing osimertinib-resistant tumors. Taken together, we conclude that Laminin α5/FAK signaling is responsible for IL-6-induced osimertinib resistance, which could be reversed by combination of ibrutinib and osimertinib." @default.
• W4213306515 created "2022-02-24" @default.
• W4213306515 creator A5007825172 @default.
• W4213306515 creator A5010171906 @default.
• W4213306515 creator A5026251593 @default.
• W4213306515 creator A5029578429 @default.
• W4213306515 creator A5040601958 @default.
• W4213306515 creator A5046507515 @default.
• W4213306515 creator A5052965872 @default.
• W4213306515 creator A5053093810 @default.
• W4213306515 creator A5054002599 @default.
• W4213306515 creator A5063920010 @default.
• W4213306515 creator A5072688588 @default.
• W4213306515 creator A5080552560 @default.
• W4213306515 creator A5082150792 @default.
• W4213306515 creator A5090390291 @default.
• W4213306515 creator A5090917855 @default.
• W4213306515 date "2022-02-23" @default.
• W4213306515 modified "2023-10-14" @default.
• W4213306515 title "Ibrutinib reverses IL-6-induced osimertinib resistance through inhibition of Laminin α5/FAK signaling" @default.
• W4213306515 cites W1945997263 @default.
• W4213306515 cites W1971394991 @default.
• W4213306515 cites W1996220028 @default.
• W4213306515 cites W2007001839 @default.
• W4213306515 cites W2035618305 @default.
• W4213306515 cites W2039432759 @default.
• W4213306515 cites W2044423100 @default.
• W4213306515 cites W2066367871 @default.
• W4213306515 cites W2068652698 @default.
• W4213306515 cites W2097147259 @default.
• W4213306515 cites W2108535907 @default.
• W4213306515 cites W2120746247 @default.
• W4213306515 cites W2121211805 @default.
• W4213306515 cites W2135036700 @default.
• W4213306515 cites W2140729960 @default.
• W4213306515 cites W2149107731 @default.
• W4213306515 cites W2154132418 @default.
• W4213306515 cites W2154137270 @default.
• W4213306515 cites W2159675211 @default.
• W4213306515 cites W2171771895 @default.
• W4213306515 cites W2180527932 @default.
• W4213306515 cites W2417242092 @default.
• W4213306515 cites W2514059094 @default.
• W4213306515 cites W2576516298 @default.
• W4213306515 cites W2605449696 @default.
• W4213306515 cites W2608850769 @default.
• W4213306515 cites W2624411770 @default.
• W4213306515 cites W2767479469 @default.
• W4213306515 cites W2786987313 @default.
• W4213306515 cites W2789940272 @default.
• W4213306515 cites W2790922923 @default.
• W4213306515 cites W2795796546 @default.
• W4213306515 cites W2885289995 @default.
• W4213306515 cites W2888869040 @default.
• W4213306515 cites W2891909134 @default.
• W4213306515 cites W2900569176 @default.
• W4213306515 cites W2924349320 @default.
• W4213306515 cites W2976431901 @default.
• W4213306515 cites W2990041408 @default.
• W4213306515 cites W2991589131 @default.
• W4213306515 cites W3002011373 @default.
• W4213306515 cites W3043250176 @default.
• W4213306515 cites W3094875479 @default.
• W4213306515 cites W3111413125 @default.
• W4213306515 doi "https://doi.org/10.1038/s42003-022-03111-7" @default.
• W4213306515 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35197546" @default.
• W4213306515 hasPublicationYear "2022" @default.
• W4213306515 type Work @default.
• W4213306515 citedByCount "9" @default.
• W4213306515 countsByYear W42133065152022 @default.
• W4213306515 countsByYear W42133065152023 @default.
• W4213306515 crossrefType "journal-article" @default.
• W4213306515 hasAuthorship W4213306515A5007825172 @default.
• W4213306515 hasAuthorship W4213306515A5010171906 @default.
• W4213306515 hasAuthorship W4213306515A5026251593 @default.
• W4213306515 hasAuthorship W4213306515A5029578429 @default.
• W4213306515 hasAuthorship W4213306515A5040601958 @default.
• W4213306515 hasAuthorship W4213306515A5046507515 @default.
• W4213306515 hasAuthorship W4213306515A5052965872 @default.
• W4213306515 hasAuthorship W4213306515A5053093810 @default.
• W4213306515 hasAuthorship W4213306515A5054002599 @default.
• W4213306515 hasAuthorship W4213306515A5063920010 @default.
• W4213306515 hasAuthorship W4213306515A5072688588 @default.
• W4213306515 hasAuthorship W4213306515A5080552560 @default.
• W4213306515 hasAuthorship W4213306515A5082150792 @default.
• W4213306515 hasAuthorship W4213306515A5090390291 @default.
• W4213306515 hasAuthorship W4213306515A5090917855 @default.
• W4213306515 hasBestOaLocation W42133065151 @default.
• W4213306515 hasConcept C121608353 @default.
• W4213306515 hasConcept C126322002 @default.
• W4213306515 hasConcept C2777626846 @default.
• W4213306515 hasConcept C2778087573 @default.
• W4213306515 hasConcept C2779438470 @default.
• W4213306515 hasConcept C2779998722 @default.
• W4213306515 hasConcept C502942594 @default.
• W4213306515 hasConcept C526805850 @default.
• W4213306515 hasConcept C71924100 @default.
• W4213306515 hasConceptScore W4213306515C121608353 @default.
• W4213306515 hasConceptScore W4213306515C126322002 @default.
• W4213306515 hasConceptScore W4213306515C2777626846 @default.

• next